Pharmaids [PHARMAID] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Pharmaids Pharmaceuticals Limited

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharmaids Pharmaceuticals Limited wins in 3 metrics, Innova Captab Ltd. wins in 15 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pharmaids Pharmaceuticals Limited Innova Captab Ltd. Better
P/E Ratio (TTM) 2,023.33 31.20 Innova Captab Ltd.
Price-to-Book Ratio 2.11 4.05 Pharmaids Pharmaceuticals Limited
Debt-to-Equity Ratio 39.24 32.95 Innova Captab Ltd.
PEG Ratio 74.19 1.33 Innova Captab Ltd.
EV/EBITDA -7.84 20.49 Innova Captab Ltd.
Profit Margin (TTM) -54.23% 8.85% Innova Captab Ltd.
Operating Margin (TTM) -54.88% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) N/A 12.88% N/A
Return on Equity -19.58% 13.37% Innova Captab Ltd.
Return on Assets (TTM) -8.99% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-264.72M $-1.09B Pharmaids Pharmaceuticals Limited
Dividend Yield N/A 0.30% N/A
1-Year Return -50.97% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 4.28 2.76 Innova Captab Ltd.
Enterprise Value $1.29B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 5.05 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 56.76% 35.19% Pharmaids Pharmaceuticals Limited
Revenue per Share (TTM) $7 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $-5.13 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.06 -0.33 Innova Captab Ltd.

Pharmaids Pharmaceuticals Limited vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

PHARMAID
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids Pharmaceuticals Limited-1.88%-2.05%-8.42%-22.03%-45.59%-43.03%
Innova Captab Ltd.-0.63%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids Pharmaceuticals Limited-50.97%1.30%33.07%991.37%692.17%205.54%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Pharmaids Pharmaceuticals Limited vs Innova Captab Ltd.

MetricPHARMAIDINNOVACAP
Market Information
Market Cap i₹1.09B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,801578,151
90 Day Avg. Volume i13,247217,693
Last Close₹27.18₹857.00
52 Week Range₹25.60 - ₹70.00₹622.00 - ₹1,020.70
% from 52W High-61.17%-16.04%
All-Time High₹87.46 (Nov 11, 2024)₹1,260.00 (Jan 06, 2025)
% from All-Time High-68.92%-31.98%
Growth Metrics
Quarterly Revenue Growth0.15%0.42%
Quarterly Earnings Growth0.15%0.23%
Financial Health
Profit Margin (TTM) i-0.54%0.09%
Operating Margin (TTM) i-0.55%0.13%
Return on Equity (TTM) i-0.20%0.13%
Debt to Equity (MRQ) i39.2432.95
Cash & Liquidity
Book Value per Share (MRQ)₹14.65₹178.28
Cash per Share (MRQ)₹0.07₹10.22
Operating Cash Flow (TTM) i₹-278,094,000₹282.88M
Levered Free Cash Flow (TTM) i₹-107,766,000₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Pharmaids Pharmaceuticals Limited vs Innova Captab Ltd.

MetricPHARMAID (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i2,023.3331.20
Forward P/E iN/A21.90
PEG Ratio i74.191.33
Price to Sales (TTM) i4.282.76
Price to Book (MRQ) i2.114.05
Market Capitalization
Market Capitalization i₹1.09B₹41.43B
Enterprise Value i₹1.29B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i5.052.90
Enterprise to EBITDA i-7.8420.49
Risk & Other Metrics
Beta i0.06-0.33
Book Value per Share (MRQ) i₹14.65₹178.28

Financial Statements Comparison: Pharmaids Pharmaceuticals Limited vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPHARMAID (2025)INNOVACAP (2025)
Revenue/Sales i188.13M12.34B
Cost of Goods Sold i142.75M8.38B
COGS % of Revenue i75.9%67.9%
Gross Profit i45.38M3.96B
Gross Margin i24.1%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i-151.64M1.65B
Operating Margin i-80.6%13.4%
EBITDA i-127.33M2.00B
EBITDA Margin i-67.7%16.2%
Pre-Tax Income i-172.79M1.71B
Pre-Tax Income % of Revenue i-91.8%13.9%
Income Tax i-37.74M427.58M
Income Tax % of Revenue i-20.1%3.5%
Net Income (Profit) i-135.05M1.28B
Profit Margin i-71.8%10.4%

Balance Sheet & Liquidity Metrics

MetricPHARMAID (2025)INNOVACAP (2025)
Cash & Equivalents i21.45M155.19M
Total Current Assets i223.07M7.03B
Total Current Assets % of Revenue i118.6%57.0%
Total Current Liabilities i287.15M3.53B
Total Current Liabilities % of Revenue i152.6%28.6%
Long-Term Debt i331.19M2.45B
Long-Term Debt % of Revenue i176.0%19.8%
Total Shareholders Equity i550.42M9.59B
Retained Earnings i-266.77M4.53B
Retained Earnings % of Revenue i-141.8%36.7%
Property, Plant & Equipment i19.32M442.93M

Cash Flow Statement Comparison

MetricPHARMAID (2025)INNOVACAP (2025)
Operating Cash Flow i-278.09M282.88M
Operating Cash Flow % of Revenue i-147.8%2.3%
Capital Expenditures i-122.62M-1.72B
Free Cash Flow i-264.72M-1.09B
FCF Margin i-140.7%-8.8%
Debt Repayment i-49.10M-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i35.27M57.22M
Float Shares i6.95M15.91M
% Held by Insiders i83.97%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i16.03%8.59%

Dividend Analysis & Yield Comparison: Pharmaids Pharmaceuticals Limited vs Innova Captab Ltd.

MetricPHARMAIDINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026